Cited by 349Clostridium difficile and Clostridium perfringens researchGut microbiota and healthInfection Control in Healthcare

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised Hosts

Open access

Lawley, Trevor D., Clare, Simon, Walker, Alan W., Goulding, David, Stabler, Richard A., Croucher, Nicholas, Mastroeni, Piero, Scott, Paul, Raisen, Claire, Mottram, Lynda, Fairweather, Neil F., Wren, Brendan W., Parkhill, Julian, Dougan, Gordon·2009·Infection and Immunity

DOI 10.1128/iai.00558-09PMC PMC2737984

Open this paper in CoChat — free account

Abstract

Clostridium difficile persists in hospitals by exploiting an infection cycle that is dependent on humans shedding highly resistant and infectious spores. Here we show that human virulent C. difficile can asymptomatically colonize the intestines of immunocompetent mice, establishing a carrier state that persists for many months. C. difficile carrier mice consistently shed low levels of spores but, surprisingly, do not transmit infection to cohabiting mice. However, antibiotic treatment of carriers triggers a highly contagious supershedder state, characterized by a dramatic reduction in the intestinal microbiota species diversity, C. difficile overgrowth, and excretion of high levels of spores. Stopping antibiotic treatment normally leads to recovery of the intestinal microbiota species diversity and suppresses C. difficile levels, although some mice persist in the supershedding state for extended periods. Spore-mediated transmission to immunocompetent mice treated with antibiotics results in self-limiting mucosal inflammation of the large intestine. In contrast, transmission to mice whose innate immune responses are compromised (Myd88 −/− ) leads to a severe intestinal disease that is often fatal. Thus, mice can be used to investigate distinct stages of the C. difficile infection cycle and can serve as a valuable surrogate for studying the spore-mediated transmission and interactions between C. difficile and the host and its microbiota, and the results obtained should guide infection control measures.

Integrity signals

Registry

Crossref · 10.1128/iai.00558-09

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB
DeSantis, T. Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E. L., Keller, K., Huber, T., Dalevi, D., Hu, P., & Andersen, G. L. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.03006-05 · Cited by 10,891
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Evolution of mammals and their gut microbes
Ley, R. E., Hamady, M., Lozupone, C., Turnbaugh, P. J., Ramey, R. R., Bircher, J. S., Schlegel, M. L., Tucker, T. A., Schrenzel, M. D., Knight, R., et al. (2008) · Science · doi:10.1126/science.1155725 · Cited by 3,747
Introducing DOTUR, a Computer Program for Defining Operational Taxonomic Units and Estimating Species Richness
Schloss, P. D., & Handelsman, J. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1501-1506.2005 · Cited by 2,529
Superspreading and the effect of individual variation on disease emergence
Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E., & Getz, W. M. (2005) · Nature · doi:10.1038/nature04153 · Cited by 2,514
The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.
Adachi, O., Kawai, T., Takeda, K., Matsumoto, M., Tsutsui, H., Sakagami, M., Nakanishi, K., & Akira, S. (1998) · Immunity · doi:10.1016/s1074-7613(00)80596-8 · Cited by 2,358
Clostridium difficile— More Difficult Than Ever
Kelly, C. P., & LaMont, J. T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707500 · Cited by 1,330

Show all 66 references

Research works printed but not linked: 1

Invasion ecology 2007 vol. 1

Sorted by citations

Gut microbiota in health and disease
Sekirov, I., Russell, S. L., Antunes, L. C. M., & Finlay, B. B. (2010) · Physiological Reviews · doi:10.1152/physrev.00045.2009 · Cited by 4,182
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
Impacts of biodiversity on the emergence and transmission of infectious diseases
Keesing, F., Belden, L. K., Daszak, P., Dobson, A., Harvell, C. D., Holt, R. D., Hudson, P., Jolles, A., Jones, K. E., Mitchell, C. E., et al. (2010) · Nature · doi:10.1038/nature09575 · Cited by 2,043
Dominant and diet-responsive groups of bacteria within the human colonic microbiota
Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M., Holtrop, G., Ze, X., Brown, D., Stares, M. D., Scott, P., Bergerat, A., et al. (2011) · The ISME Journal · doi:10.1038/ismej.2010.118 · Cited by 1,632
Self-citation
Control of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625
Microbiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564
Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation
Browne, H. P., Forster, S. C., Anonye, B. O., Kumar, N., Neville, B. A., Stares, M. D., Goulding, D., & Lawley, T. D. (2016) · Nature · doi:10.1038/nature17645 · Cited by 1,299
Self-citation
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B. C., Monack, D. M., et al. (2013) · Nature · doi:10.1038/nature12503 · Cited by 1,035
Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans
Ubeda, C., Taur, Y., Jenq, R. R., Equinda, M. J., Son, T., Samstein, M., Viale, A., Socci, N. D., van den Brink, M. R. M., Kamboj, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43918 · Cited by 943
Antibiotics and the Human Gut Microbiome: Dysbioses and Accumulation of Resistances
Francino, M. P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01543 · Cited by 990
Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier
Martens, E. C., Neumann, M., & Desai, M. S. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0036-x · Cited by 711
Sequencing ancient calcified dental plaque shows changes in oral microbiota with dietary shifts of the Neolithic and Industrial revolutions
Adler, C. J., Dobney, K., Weyrich, L. S., Kaidonis, J., Walker, A. W., Haak, W., Bradshaw, C. J. A., Townsend, G., Sołtysiak, A., Alt, K. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2536 · Cited by 621
Self-citation
Intestinal colonization resistance
Lawley, T. D., & Walker, A. W. (2013) · Immunology · doi:10.1111/j.1365-2567.2012.03616.x · Cited by 610
Self-citation
Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis
Buffie, C. G., Jarchum, I., Equinda, M., Lipuma, L., Gobourne, A., Viale, A., Ubeda, C., Xavier, J., & Pamer, E. G. (2012) · Infection and Immunity · doi:10.1128/iai.05496-11 · Cited by 596
Role of the Commensal Microbiota in Normal and Pathogenic Host Immune Responses
Littman, D. R., & Pamer, E. G. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.004 · Cited by 568
Clostridium difficile colitis: pathogenesis and host defence
Abt, M. C., McKenney, P. T., & Pamer, E. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.108 · Cited by 575
Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice
Lawley, T. D., Clare, S., Walker, A. W., Stares, M. D., Connor, T. R., Raisen, C., Goulding, D., Rad, R., Schreiber, F., Brandt, C., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002995 · Cited by 540
Self-citation
Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients
Cox, M. J., Allgaier, M., Taylor, B., Baek, M. S., Huang, Y. J., Daly, R. A., Karaöz, U., Andersen, G. L., Brown, R., Fujimura, K. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011044 · Cited by 458
Mechanisms controlling pathogen colonization of the gut
Stecher, B., & Hardt, W. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.10.003 · Cited by 431
Sinus Microbiome Diversity Depletion and Corynebacterium tuberculostearicum Enrichment Mediates Rhinosinusitis
Abreu, N. A., Nagalingam, N. A., Song, Y., Roediger, F. C., Pletcher, S. D., Goldberg, A. N., & Lynch, S. V. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003783 · Cited by 415
Role of the gut microbiota in defining human health
Fujimura, K. E., Slusher, N. A., Cabana, M. D., & Lynch, S. V. (2010) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.14 · Cited by 421
“Blooming” in the gut: how dysbiosis might contribute to pathogen evolution.
Stecher, B., Maier, L., & Hardt, W.-D. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2989 · Cited by 378
The Clostridium difficile spo0A Gene Is a Persistence and Transmission Factor
Deakin, L. J., Clare, S., Fagan, R. P., Dawson, L. F., Pickard, D., West, M. R., Wren, B. W., Fairweather, N. F., Dougan, G., & Lawley, T. D. (2012) · Infection and Immunity · doi:10.1128/iai.00147-12 · Cited by 373
Self-citation
Antibiotics, microbiota, and immune defense
Úbeda, C., & Pamer, E. G. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.05.003 · Cited by 369
Clostridium difficile Toxin CDT Induces Formation of Microtubule-Based Protrusions and Increases Adherence of Bacteria
Schwan, C., Stecher, B., Tzivelekidis, T., van Ham, M., Rohde, M., Hardt, W., Wehland, J., & Aktories, K. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000626 · Cited by 354
No Vacancy: How Beneficial Microbes Cooperate with Immunity To Provide Colonization Resistance to Pathogens
Sassone‐Corsi, M., & Raffatellu, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403169 · Cited by 346
Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections
Carter, G. P., Chakravorty, A., Nguyen, T. A. P., Mileto, S. J., Schreiber, F., Li, L. Q., Howarth, P. M., Clare, S., Cunningham, B. A., Sambol, S. P., et al. (2015) · mBio · doi:10.1128/mbio.00551-15 · Cited by 326
Self-citation
Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial
Freedberg, D. E., Toussaint, N. C., Chen, S. P., Ratner, A. J., Whittier, S., Wang, T. C., Wang, H. H., & Abrams, J. A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.043 · Cited by 322
Understanding Clostridium difficile Colonization
Crobach, M. J. T., Vernon, J. J., Loo, V. G., Kong, L. Y., Péchiné, S., Wilcox, M. H., & Kuijper, E. J. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00021-17 · Cited by 329
From superspreaders to disease hotspots: linking transmission across hosts and space
Paull, S. H., Song, S., McClure, K. M., Cassin‐Sackett, L., Kilpatrick, A. M., & Johnson, P. T. J. (2011) · Frontiers in Ecology and the Environment · doi:10.1890/110111 · Cited by 314
Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection
Abt, M. C., Lewis, B. B., Caballero, S., Xiong, H., Carter, R. A., Sušac, B., Ling, L., Leiner, I. M., & Pamer, E. G. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.06.011 · Cited by 293
Multiple Factors Modulate Biofilm Formation by the Anaerobic Pathogen Clostridium difficile
Thapa, T. B., Leuzzi, R., Ng, Y. K., Baban, S. T., Adamo, R., Kuehne, S. A., Scarselli, M., Minton, N. P., Serruto, D., & Unnikrishnan, M. (2012) · Journal of Bacteriology · doi:10.1128/jb.01980-12 · Cited by 287
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection
Khan, I., Bai, Y., Zha, L., Ullah, N., Ullah, H., Shah, S. R. H., Sun, H., & Zhang, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.716299 · Cited by 291
Clostridium difficile infection in the community: a zoonotic disease?
Hensgens, M. P. M., Keessen, E. C., Squire, M. M., Riley, T. V., Koene, M. G. J., Boer, E. D., Lipman, L. J. A., & Kuijper, E. J. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03853.x · Cited by 304
The interplay between microbiome dynamics and pathogen dynamics in a murine model ofClostridium difficileInfection
Reeves, A. E., Theriot, C. M., Bergin, I. L., Huffnagle, G. B., Schloss, P. D., & Young, V. B. (2011) · Gut Microbes · doi:10.4161/gmic.2.3.16333 · Cited by 277
Effect of Antibiotic Treatment on the Intestinal Metabolome
Antunes, L. C. M., Han, J., Ferreira, R. B. R., Lolić, P., Borchers, C. H., & Finlay, B. B. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01664-10 · Cited by 271
Clostridium difficile and the microbiota
Seekatz, A. M., & Young, V. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72336 · Cited by 255
Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model
Hryckowian, A. J., Treuren, W. V., Smits, S. A., Davis, N. M., Gardner, J. O., Bouley, D. M., & Sonnenburg, J. L. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0150-6 · Cited by 239
Microbiota-mediated inflammation and antimicrobial defense in the intestine
Caballero, S., & Pamer, E. G. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120238 · Cited by 238
Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance
Britton, R. A., & Young, V. B. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.04.001 · Cited by 244
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection
Stecher, B. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0008-2014 · Cited by 250
The Etiology and Pathogenesis of Chronic Rhinosinusitis: a Review of Current Hypotheses
Lam, K. K., Schleimer, R. P., & Kern, R. C. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0540-2 · Cited by 236
Clostridium difficile infection
Vedantam, G., Clark, A. E., Chu, M., McQuade, R., Mallozzi, M., & Viswanathan, V. K. (2012) · Gut Microbes · doi:10.4161/gmic.19399 · Cited by 210
A Role for TLR4 in Clostridium difficile Infection and the Recognition of Surface Layer Proteins
Ryan, A. W., Lynch, M. J., Smith, S. M., Amu, S., Nel, H. J., McCoy, C. E., Dowling, J. K., Draper, E., O’Reilly, V. P., McCarthy, C., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002076 · Cited by 197
Metabolism of Bile Salts in Mice Influences Spore Germination in Clostridium difficile
Giel, J. L., Sorg, J. A., Sonenshein, A. L., & Zhu, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008740 · Cited by 202
Cyclic Diguanylate Inversely Regulates Motility and Aggregation in Clostridium difficile
Purcell, E. B., McKee, R. W., McBride, S. M., Waters, C. M., & Tamayo, R. (2012) · Journal of Bacteriology · doi:10.1128/jb.00100-12 · Cited by 191
Cefoperazone-treated mice as an experimental platform to assess differential virulence ofClostridium difficilestrains
Theriot, C. M., Koumpouras, C. C., Carlson, P. E., Bergin, I. L., Aronoff, D. M., & Young, V. B. (2011) · Gut Microbes · doi:10.4161/gmic.19142 · Cited by 190
Nucleotide-Binding Oligomerization Domain 1 Mediates Recognition of Clostridium difficile and Induces Neutrophil Recruitment and Protection against the Pathogen
Hasegawa, M., Yamazaki, T., Kamada, N., Tawaratsumida, K., Kim, Y., Núñez, G., & Inohara, N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003761 · Cited by 187
The streptomycin mouse model for Salmonella diarrhea: functional analysis of the microbiota, the pathogen’s virulence factors, and the host’s mucosal immune response
Kaiser, P., Diard, M., Stecher, B., & Hardt, W. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01070.x · Cited by 184
Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Song, Y., Garg, S., Girotra, M., Maddox, C., von Rosenvinge, E. C., Dutta, A., Dutta, S., & Fricke, W. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081330 · Cited by 172
Clostridium difficile Toxins: Mediators of Inflammation
Shen, A. (2012) · Journal of Innate Immunity · doi:10.1159/000332946 · Cited by 171
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options
Bella, S. D., Sanson, G., Monticelli, J., Zerbato, V., Principe, L., Giuffrè, M., Pipitone, G., & Luzzati, R. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00135-23 · Cited by 202
Biology and Diseases of Mice
Whary, M. T., Baumgarth, N., Fox, J. G., & Barthold, S. W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-409527-4.00003-1 · Cited by 168
When pathogenic bacteria meet the intestinal microbiota
Rolhion, N., & Chassaing, B. (2016) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2015.0504 · Cited by 169
Characterisation of Clostridium difficile Biofilm Formation, a Role for Spo0A
Dawson, L. F., Valiente, E., Faulds‐Pain, A., Donahue, E. H., & Wren, B. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050527 · Cited by 158
Self-citation
The Anti-Sigma Factor TcdC Modulates Hypervirulence in an Epidemic BI/NAP1/027 Clinical Isolate of Clostridium difficile
Carter, G. P., Douce, G. R., Govind, R., Howarth, P. M., Mackin, K. E., Spencer, J., Buckley, A. M., Antunes, A. P. D. O. L., Kotsanas, D., Jenkin, G., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002317 · Cited by 158
Crossing the scale from within-host infection dynamics to between-host transmission fitness: a discussion of current assumptions and knowledge
Handel, A., & Rohani, P. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0302 · Cited by 154
Critical Role for MyD88-Mediated Neutrophil Recruitment during Clostridium difficile Colitis
Jarchum, I., Liu, M., Shi, C., Equinda, M. J., & Pamer, E. G. (2012) · Infection and Immunity · doi:10.1128/iai.00448-12 · Cited by 153
Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection
Hirsch, B. E., Saraiya, N., Poeth, K., Schwartz, R. M., Epstein, M. E., & Honig, G. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0930-z · Cited by 158
Virulence factors of Clostridium difficile and their role during infection
Janoir, C. (2015) · Anaerobe · doi:10.1016/j.anaerobe.2015.10.009 · Cited by 169
Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease
Seekatz, A. M., Theriot, C. M., Molloy, C. T., Wozniak, K. L., Bergin, I. L., & Young, V. B. (2015) · Infection and Immunity · doi:10.1128/iai.00459-15 · Cited by 141
Cyclic Di-GMP Riboswitch-Regulated Type IV Pili Contribute to Aggregation of Clostridium difficile
Bordeleau, É., Purcell, E. B., Lafontaine, D. A., Fortier, L., Tamayo, R., & Burrus, V. (2014) · Journal of Bacteriology · doi:10.1128/jb.02340-14 · Cited by 151
Clostridium difficilevirulence factors: Insights into an anaerobic spore-forming pathogen
Awad, M. M., Johanesen, P., Carter, G. P., Rose, E., & Lyras, D. (2014) · Gut Microbes · doi:10.4161/19490976.2014.969632 · Cited by 142
Adaptive Strategies and Pathogenesis of Clostridium difficile fromIn VivoTranscriptomics
Janoir, C., Denève-Larrazet, C., Bouttier, S., Barbut, F., Hoÿs, S., Caleechum, L., Chapetón-Montes, D., Pereira, F. C., Henriques, A. O., Collignon, A., et al. (2013) · Infection and Immunity · doi:10.1128/iai.00515-13 · Cited by 140
The intestinal microbiota and susceptibility to infection in immunocompromised patients
Taur, Y., & Pamer, E. G. (2013) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283630dd3 · Cited by 144
Antibiotic-induced collateral damage to the microbiota and associated infections
de Nies, L., Kobras, C. M., & Stracy, M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00936-9 · Cited by 156
Para-cresol production by Clostridium difficile affects microbial diversity and membrane integrity of Gram-negative bacteria
Passmore, I. J., Letertre, M. P. M., Preston, M. D., Bianconi, I., Harrison, M. A., Nasher, F., Kaur, H., Hong, H. A., Baines, S. D., Cutting, S. M., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007191 · Cited by 141
Self-citation
IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
Frisbee, A. L., Saleh, M. M., Young, M. K., Leslie, J. L., Simpson, M. D., Abhyankar, M. M., Cowardin, C. A., Ma, J. Z., Pramoonjago, P., Turner, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10733-9 · Cited by 134
Models for the study of Clostridium difficile infection
Best, E. L., Freeman, J., & Wilcox, M. H. (2012) · Gut Microbes · doi:10.4161/gmic.19526 · Cited by 135
Toll-Like Receptor 5 Stimulation Protects Mice from Acute Clostridium difficile Colitis
Jarchum, I., Liu, M., Lipuma, L., & Pamer, E. G. (2011) · Infection and Immunity · doi:10.1128/iai.01196-10 · Cited by 130
Pathogenicity and virulence of Clostridioides difficile
Buddle, J. E., & Fagan, R. P. (2022) · Virulence · doi:10.1080/21505594.2022.2150452 · Cited by 147
Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome
Steinway, S. N., Biggs, M. B., Loughran, T. P., Papin, J. A., & Albert, R. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004338 · Cited by 130
A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity
Gebhart, D., Lok, S., Clare, S., Tomas, M., Stares, M., Scholl, D., Donskey, C. J., Lawley, T. D., & Govoni, G. R. (2015) · mBio · doi:10.1128/mbio.02368-14 · Cited by 127
Self-citation
Functional genomics reveals that Clostridium difficileSpo0A coordinates sporulation, virulence and metabolism
Pettit, L. J., Browne, H. P., Yu, L., Smits, W. K., Fagan, R. P., Barquist, L., Martin, M. J., Goulding, D., Duncan, S. H., Flint, H. J., et al. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-160 · Cited by 127
Self-citation
Bacterial Community Interactions During Chronic Respiratory Disease
Welp, A. L., & Bomberger, J. M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00213 · Cited by 134
Use of Purified Clostridium difficile Spores To Facilitate Evaluation of Health Care Disinfection Regimens
Lawley, T. D., Clare, S., Deakin, L. J., Goulding, D., Yen, J. L., Raisen, C. L., Brandt, C., Lovell, J., Cooke, F. J., Clark, T. G., et al. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.00718-10 · Cited by 130
Self-citation
Salmonella-Induced Mucosal Lectin RegIIIβ Kills Competing Gut Microbiota
Stelter, C., Käppeli, R., König, C., Krah, A., Hardt, W., Stecher, B., & Bumann, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020749 · Cited by 123
Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection
Vincent, C., Stephens, D. A., Loo, V. G., Edens, T. J., Behr, M. A., Dewar, K., & Manges, A. R. (2013) · Microbiome · doi:10.1186/2049-2618-1-18 · Cited by 123
Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?
Fang, F. C., Polage, C. R., & Wilcox, M. H. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02463-16 · Cited by 119
Short chain and polyunsaturated fatty acids in host gut health and foodborne bacterial pathogen inhibition
Peng, M., & Biswas, D. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1203286 · Cited by 122
Functional Characterization of Clostridium difficile Spore Coat Proteins
Permpoonpattana, P., Phetcharaburanin, J., Mikelsone, A., Dembek, M., Tan, S., Brisson, M., Ragione, R. M. L., Brisson, A. R., Fairweather, N. F., Hong, H. A., et al. (2013) · Journal of Bacteriology · doi:10.1128/jb.02104-12 · Cited by 123
Self-citation
Emerging insights on intestinal dysbiosis during bacterial infections
Pham, T. A. N., & Lawley, T. D. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.12.002 · Cited by 122
Self-citation
Identification of a Genetic Locus Responsible for Antimicrobial Peptide Resistance in Clostridium difficile
McBride, S. M., & Sonenshein, A. L. (2010) · Infection and Immunity · doi:10.1128/iai.00731-10 · Cited by 116
Mouse Relapse Model of Clostridium difficile Infection
Sun, X., Wang, H., Zhang, Y., Chen, K., Davis, B. J., & Feng, H. (2011) · Infection and Immunity · doi:10.1128/iai.01336-10 · Cited by 115
Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns
Pamer, E. G. (2014) · Mucosal Immunology · doi:10.1038/mi.2013.117 · Cited by 113
Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance
Johanesen, P., Mackin, K. E., Hutton, M. L., Awad, M. M., Larcombe, S., Amy, J., & Lyras, D. (2015) · Genes · doi:10.3390/genes6041347 · Cited by 112
The Enterotoxicity of Clostridium difficile Toxins
Sun, X., Savidge, T., & Feng, H. (2010) · Toxins · doi:10.3390/toxins2071848 · Cited by 110
Surface Layers of Clostridium difficile Endospores
Permpoonpattana, P., Tolls, E. H., Nadem, R., Tan, S., Brisson, A. R., & Cutting, S. M. (2011) · Journal of Bacteriology · doi:10.1128/jb.05182-11 · Cited by 118
Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis
Li, M., Liang, P., Li, Z., Wang, Y., Zhang, G., Gao, H., Shu, W., & Tang, L. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00692 · Cited by 109
Clostridium difficileinfection
Viswanathan, V. K., Mallozzi, M., & Vedantam, G. (2010) · Gut Microbes · doi:10.4161/gmic.1.4.12706 · Cited by 109
Gut microbiome shifts with urbanization and potentially facilitates a zoonotic pathogen in a wading bird
Murray, M. H., Lankau, E. W., Kidd, A. D., Welch, C. N., Ellison, T. J., Adams, H. C., Lipp, E. K., & Hernandez, S. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0220926 · Cited by 110
The agr Locus Regulates Virulence and Colonization Genes in Clostridium difficile 027
Martin, M. J., Clare, S., Goulding, D., Faulds‐Pain, A., Barquist, L., Browne, H. P., Pettit, L. J., Gordon Dougan, B., Lawley, T. D., & Wren, B. W. (2013) · Journal of Bacteriology · doi:10.1128/jb.00473-13 · Cited by 102
Self-citation
Type IV Pili Promote Clostridium difficile Adherence and Persistence in a Mouse Model of Infection
McKee, R. W., Aleksanyan, N., Garrett, E. M., & Tamayo, R. (2018) · Infection and Immunity · doi:10.1128/iai.00943-17 · Cited by 101
The Clostridium difficile Cell Wall Protein CwpV is Antigenically Variable between Strains, but Exhibits Conserved Aggregation-Promoting Function
Reynolds, C. B., Emerson, J. E., de la Riva, L., Fagan, R. P., & Fairweather, N. F. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002024 · Cited by 99
Self-citation
Spore Cortex Hydrolysis Precedes Dipicolinic Acid Release during Clostridium difficile Spore Germination
Francis, M. B., Allen, C. A., & Sorg, J. A. (2015) · Journal of Bacteriology · doi:10.1128/jb.02575-14 · Cited by 104
Biofilm formation by Clostridium difficile
Đapa, T., & Unnikrishnan, M. (2013) · Gut Microbes · doi:10.4161/gmic.25862 · Cited by 98
Animal Model To Study Klebsiella pneumoniae Gastrointestinal Colonization and Host-to-Host Transmission
Young, T. M., Bray, A. S., Nagpal, R. K., Caudell, D. L., Yadav, H., & Zafar, M. A. (2020) · Infection and Immunity · doi:10.1128/iai.00071-20 · Cited by 96
Variations in Virulence and Molecular Biology among Emerging Strains of Clostridium difficile
Hunt, J. J., & Ballard, J. D. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00017-13 · Cited by 96
Emergence of dominant multidrug-resistant bacterial clades: Lessons from history and whole-genome sequencing
Klemm, E. J., Wong, V., & Dougan, G. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717162115 · Cited by 95
Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study
Langdon, A. E., Schwartz, D. J., Bulow, C., Sun, X., Hink, T., Reske, K. A., Jones, C. R., Burnham, C. D., Dubberke, E. R., & Dantas, G. A. (2021) · Genome Medicine · doi:10.1186/s13073-021-00843-9 · Cited by 90

Authors: Lawley, T. D., Clare, S., Walker, A. W., Goulding, D., Stabler, R. A., Croucher, N., Mastroeni, P., Scott, P., Raisen, C., Mottram, L., Fairweather, N. F., Wren, B. W., Parkhill, J., & Dougan, G.
Affiliations: Microbial Pathogenesis Laboratory
Wellcome Sanger Institute (GB)
University of London (GB)
Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom
Imperial College London (GB)
Corresponding author: Lawley, Trevor D.
ORCID: Lawley, Trevor D.
Clare, Simon
Walker, Alan W.
Goulding, David
Stabler, Richard A.
Croucher, Nicholas
Mottram, Lynda
Fairweather, Neil F.
Wren, Brendan W.
Parkhill, Julian
Venue: Infection and Immunity
Publisher: American Society for Microbiology
Published: 2009-09
Volume: 77
Issue: 9
Pages: 3661-3669
ISSN: 0019-9567 (ISSN-L)
1098-5522
DOI: 10.1128/iai.00558-09
PMC: PMC2737984
OpenAlex: W2125181303
Cited by: 349
References: 66
Citations by year: 2026: 5 · 2025: 12 · 2024: 15 · 2023: 16 · 2022: 9 · 2021: 29 · 2020: 23 · 2019: 21 · 2018: 23 · 2017: 14 · 2016: 21 · 2015: 34 · 2014: 30 · 2013: 31 · 2012: 24
FWCI: 14.95
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Infection and Immunity (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Wellcome Trust
Royal Society
Engineering and Physical Sciences Research Council (EP/E500412/1)
Topics: Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
Keywords: Clostridium difficile, asymptomatic carriage, antibiotic therapy, gut microbiota, MyD88 knockout mice, innate immunity, mucosal inflammation, infection cycle, infection control, mouse model
MeSH terms: Animals, Anti-Bacterial Agents, Carrier State, Enterocolitis, Pseudomembranous, Female, Intestines, Mice, Inbred C57BL, Spores, Bacterial, Clostridioides difficile, Immunocompromised Host, Mice, Myeloid Differentiation Factor 88

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised Hosts

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks